학술논문

Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, June 2023, 186:1-11)
Subject
Language
English
ISSN
18790852
09598049